Inclusion complexes of rifampicin (RP) were prepared with hydroxypropyl-β-cyclodextrin (HPβCD
INTRODUCTION
Rifampicin (RP) is a wide-spectrum antibiotic active against the most Gram-positive bacteria and variable active against Gram-negative microrganisms. Due to the development of resistance to rifampicin by many bacteria its clinical use is mainly in the treatment of tuberculosis (Reynolds, 1993) . RP ( Figure 1 ) is a potent inductor of the cytochrome P-450 of the hepatic and intestinal enzymatic system and of P-glycoprotein of the transport system, which results in numerous drug interactions and side effects (Watcher et al., 1998; Achira et al., 1999) . Thus, the interaction of RP with drug carriers to improve effectiveness and minimize side effects is of obvious relevance.
The ability of cyclodextrins (CD) to modify physicochemical properties of drugs or issues of drug toxicity is well known (Loftsson, Brewster, 1996; Montassier et al., 1997) . Because the chemical structure of the molecule, cyclodextrin includes a central hydrophobic cavity and an outer hydrophilic surface. The hydrophobic inner of cavity is a result of the electron rich environment caused mainly by the glycosidic oxygen atoms. The group of forces, including Van der Waals, hydrogen bonds and hydrophobic effects contribute to the formation of a stable complex of drugs in the apolar cavity of cyclodextrins (Bibby et al., 2001) . Thus, a large number of drug molecules can be complexed to CD modifying solubility, bioavaila bility and stability (Loftsson et al., 1991; Vianna et al., 1998; Dalmora, Oliveira, 1999; Dalmora et al., 2001; Másson et al., 1998) . Important reviews on cyclodextrin applications in the pharmaceutical field were published with details (Bibby et al., 2001; Szejtli, 1994; Loftsson, Másson, 2001) .
Several experimental procedures have been used to analyze the structural and thermodynamic parameters related to cyclodextrin inclusion complex formation (Goyenechea, et al., 2001; Connors, 1997; Bobec et al., 2000; Díaz et al., 1999; Myake et al., 1999) . Experimental procedures using NMR (Másson et al., 1998; Díaz et al., 1999; Loukas, 1997; Myake et al., 1999) , solubility analysis and UV-Vis spectroscopy (Dalmora, Oliveira, 1999; Oh et al., 1998) , molecular mechanical calculations (Montassier et al., 1997; Vianna et al., 1998; Bobek et al., 2000; Madri, et al., 1997; Myles et al., 1994) , DSC study (Bermúdez et al., 1999) and X-ray diffraction (Montassier et al., 1997; Bobek et al., 2000) are frequently used to elucidate the structure of molecular complexes.
In this work we have studied the increase of the solubility of rifampicin by molecular complexation with hydroxypropyl-β-cyclodextrin. Molecular Modelling study of the structure of HPβCD, rifampicin and RP/ HPβCD inclusion complexes were performed. The molecular complexes were also analysed by 1 H,
13
C and 15 N-NMR spectroscopy in order to characterize the structure of the inclusion complex.
MATERIAL AND METHODS

Material
Hydroxypropyl-β-cyclodextrin (HPßCD), D.S. 4.6, was purchased from CTD Inc., Florida, USA. Rifampicin (RP) [3-(4-methylpiperazinyl-iminomethyl] 
Methods
Stability Constant Determination
Amounts of RP (about 300 mg) that exceeded its solubility were weighed in a 25 mL plastic flask, to which 10 mL of buffer solution (pH 6.9) containing HPβCD with concentrations in the range of 0-100 mM was added. The mixture was kept under agitation by 24 hours at controlled temperature of 25 °C to reach steady state. Then, the material was filtered through 0.22 µm membrane. Afterwards appropriate dilution with buffer solution was performed and the concentration of rifampicin was measured by spectrophotometry at 331 nm. The solubility diagram was plotted, relating the absorbance as a function of dissolved rifampicin. The stability constant (K) was calculated using the framework of Higuchi and Connors model (Higuchi, Connors, 1965) :
Where K is the stability constant for RP/HPbCD 1:1 complex and the subscripts f and b refer to the free and bound RP, respectively.
Where slope is calculated from of the linear phase solubility diagram, and So is the intrinsic apparent solubility of RP in the absence of cyclodextrin.
The effect of the buffer and ionic strength on the formation of RP complexes were carried out in citrate buffer pH 6.9, µ =180 mM and in Tris-HCl buffer pH 6.9, µ =10 mM and 180 mM. The ionic strength was adjusted using sodium chloride.
Molecular Modelling Studies
A model of inclusion complex was investigated FIGURE 1 -Chemical structure of rifampicin.
through molecular graphic software using the Chem 3D Ultra software, version 6.0, serial number 553923 with use authorized by Cambridge Software Corporation (http:// www.cambridgesoft.com/products/ family.cfm? FID=3, 2004) . The structures of RP and HPβCD were built separately, and the conformational energy was minimized using MM2 method and force field (Schupfer, Gulacar, 2001) . A set of structures of minimum-energy was chosen, and the molecule of RP was introduced into cavity of HPβCD using docking method. Steric and electrostatic interactions between the molecules were calculated by moving the atoms of the molecules back and forth. For the simulation solvents were not considered. Following, the atoms of RP and HPßCD were allowed to move freely, and the most stable docking position of the two molecules was obtained. 
Nuclear Magnetic Resonance (NMR) Measurements
RESULTS
The analysis of the drug inclusion complex with cyclodextrin in solution can be achieved by several methods. The analysis of the drug solubilization associated to spectral changes can be used to measure the transference of the drug from the aqueous phase to the apolar cavity of cyclodextrin. If the drug has limited aqueous solubility, the concentration of solubilized drug can be increased by the inclusion in cyclodextrin.
In our results, linear responses of rifampicin concentrations dissolved against HPβCD concentrations can be observed (Figure 2) .
The phase solubility behaviors show that rifampicin followed the AL type phase solubility diagram (Másson et al., 1998) , respectively. From the results of the molecular modelling calculations for RP/HPβCD complexes it is possible to predict that the piperazine side chain of RP enclosed into HPβCD hydrophobic cavity can form the complex or with the bulkiest region of RP molecule enclosed into cyclodextrin cavity. The calculations of the minimisation energy for inclusion complex for both cases, by MM2 method, provided the values of 330 kcal/mol and 1113 kcal/mol, respectively. These results indicate that the most stable complex (due to less energy value) have the rifampicin complexed with HPβCD through the piperazine tail enclosed into the hydrophobic cavity of HPβCD and the bulky region of the molecule in the surface cavity of cyclodextrin (Figure 3 ). Nuclear magnetic resonance study at high field has been used to investigate the stoichiometries of important drug inclusion complexes. This technique provides evidence for the existence of true inclusion complexes and allows unequivocal determination of the stoichiometry for complexes obtained in the solid state, as well as in solution (Djedaini, Perly, 1991) . For the analysis of the spectra of the figures 4-7, we have used the RP structure of figure 1. for µ=0.18) show that the inclusion complexes are formed and that the solubility of antibiotic in the presence of hydroxypropyl-β-cyclodextrin increase about 6 fold in high ionic strength independently of the buffer system used. This FIGURE 2 -Solubility diagram of rifampicin with HPβCD at 25 °C. Key: ( ) 30 mM citrate buffer, pH 6.9, µ=180 mM; ( ) 10 mM Tris-HCl buffer, pH 6.9, µ=10 mM; ( ) 10 mM Tris-HCl buffer, pH 6.9, µ=180 mM. The ionic strength was adjusted with sodium chloride. Analysis of the molecular association of rifampicin 49 phenomenon can be understood since at pH 6.9 the antibiotic is a zwiterion and binds to cyclodextrin cavity by hydrophobic effect. Thus, the activity coefficient of neutral organic compounds increases with ionic strength of medium and therefore favours the transfer of the drug from hydrophilic medium to hydrophobic cavity of cyclodextrin increasing the value of the stability constant (Oliveira et al., 1997) .
We have shown that MM 2 Molecular Modelling calculations for RP/CD complex using computational tools demonstrate the experimental evidence that the complex at molar ratio 1:1 are thermodynamically stable. For RP/HPβCD complex of minimum energy it was possible to predict that the piperazine tail of RP penetrates into cyclodextrin cavity through hydrophobic interactions. However, the low values obtained for K indicate a weak bond of RP into HPβCD molecule, probably due to steric hindrance of the substitutive hydroxypropyl group of cyclodextrin, which do not allow the approach of the bulkiest region of RP molecule.
NMR studies were used to compare the chemical shift of 1 H and 13 C of rifampicin with a similar compound from literature (Fuhrer von, 1973) . However, since the D 2 O solubility of rifampicin was not good to obtain a direct detection of N for free RP and RP/HPßCD complex it was verified that only peaks of the side chain related to the piperazine ring change substantially. In fact, the data of table I show that the RP hydrogen in the positions 38 (δ 8.10 1H s) and 46 (δ 2.91 3H s) change to (8,17 bs) and (2.76-2.88 m), respectively (Table I ).
In addition, it is possible to verify that not only occur the chemical shift but also a clear multiplicity in the signal of hydrogen 46 coupled to carbon 46. On the other hand, the 15 N chemical shift for N40 changes from d 114 for free RP to 150 ppm for RP/HPßCD complex. All the carbons and hydrogens attributions are in agreement with the data founded in the literature (Fuhrer von, 1973; Gallo, et al., 1974) although the authors have used different solvents.
Thus, this group of data obtained by 2D-NMR allow suggesting that the RP was complexed with the HPßCD through the lateral chain containing piperazine ring and that the geometry of the complex is in agreement with the predictions of the Molecular Modelling Calculations.
CONCLUSIONS
The increase in the aqueous solubility of RP caused by the presence of HPbCD was dependent on the ionic strength and is one of experimental evidence of the molecular complexation. The spectroscopy analysis by 
RESUMO
Análise da associação molecular da rifampicina com hidroxipropil-β-ciclodextrina figure 1 ; ** TSPA-d4 was used as external reference in all spectra.
Foram preparados complexos de inclusão de rifampicina (RP) com hidroxipropil-β-ciclodextrina (HPβCD
